All this speculation on an involvement with a vaccine is very targetted. While important near term, don't lose sight of the fact that we import over 90% of medicines and there will be a push to reduce our reliance on imports longer term. A miopic view on this stock could be costly.
Ann: COVID19 Vaccine Feasibility Assessment, page-549
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.43M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.5¢ | $1.265K | 11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 283967 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 440913 | 7 |
View Market Depth
| Last trade - 14.04pm 03/10/2024 (20 minute delay) ? |
| IDT (ASX) Chart |